3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
7
Genitourinary
4
Endocrine
3
Gynecologic
2
Other neoplasm
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Paclitaxel
81
Carboplatin
67
pembrolizumab
62
Bevacizumab
58
Cisplatin
49
Specimen Handling
29
Drug Therapy
26
Blood Specimen Collection
23
olaparib
20
Cyclophosphamide
18
Taxes
17
Magnetic Resonance Spectroscopy
16
Letrozole
16
Gemcitabine
16
Biopsy
16
liposomal doxorubicin
15
niraparib
14
Brachytherapy
14
fludarabine
13
Radiotherapy
13
abemaciclib
12
Injections
12
Topotecan
11
Nivolumab
11
Doxorubicin
11
lenvatinib
10
Fulvestrant
10
Fluorouracil
10
Surveys and Questionnaires
9
Standard of Care
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Transurethral Resection of Prostate
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled
NCT05472311
2024-08-19
TIBA
University of Washington
Phase NA
Recruiting
565 enrolled